These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Design and SAR of new substituted purines bearing aryl groups at N9 position as HIV-1 Tat-TAR interaction inhibitors. Pang R, Zhang C, Yuan D, Yang M. Bioorg Med Chem; 2008 Sep 01; 16(17):8178-86. PubMed ID: 18693018 [Abstract] [Full Text] [Related]
5. Synthesis and assay of isoquinoline derivatives as HIV-1 Tat-TAR interaction inhibitors. He M, Yuan D, Lin W, Pang R, Yu X, Yang M. Bioorg Med Chem Lett; 2005 Sep 01; 15(17):3978-81. PubMed ID: 16039124 [Abstract] [Full Text] [Related]
6. Design, synthesis, and biological evaluation of novel quinoline derivatives as HIV-1 Tat-TAR interaction inhibitors. Chen S, Chen R, He M, Pang R, Tan Z, Yang M. Bioorg Med Chem; 2009 Mar 01; 17(5):1948-56. PubMed ID: 19217787 [Abstract] [Full Text] [Related]
7. The design, synthesis, and biological evaluation of novel substituted purines as HIV-1 Tat-TAR inhibitors. Yuan D, He M, Pang R, Lin SS, Li Z, Yang M. Bioorg Med Chem; 2007 Jan 01; 15(1):265-72. PubMed ID: 17055732 [Abstract] [Full Text] [Related]
11. Cell-dependent interference of a series of new 6-aminoquinolone derivatives with viral (HIV/CMV) transactivation. Stevens M, Balzarini J, Tabarrini O, Andrei G, Snoeck R, Cecchetti V, Fravolini A, De Clercq E, Pannecouque C. J Antimicrob Chemother; 2005 Nov 01; 56(5):847-55. PubMed ID: 16150861 [Abstract] [Full Text] [Related]
12. TAR RNA recognition by a cyclic peptidomimetic of Tat protein. Leeper TC, Athanassiou Z, Dias RL, Robinson JA, Varani G. Biochemistry; 2005 Sep 20; 44(37):12362-72. PubMed ID: 16156649 [Abstract] [Full Text] [Related]
15. Aptamers targeted to an RNA hairpin show improved specificity compared to that of complementary oligonucleotides. Darfeuille F, Reigadas S, Hansen JB, Orum H, Di Primo C, Toulmé JJ. Biochemistry; 2006 Oct 03; 45(39):12076-82. PubMed ID: 17002307 [Abstract] [Full Text] [Related]